Latest news with #smallcap
Entrepreneur
3 days ago
- Business
- Entrepreneur
Equirus Launches Offshore Small-Cap Fund from GIFT City for Global Investors
With a minimum investment requirement of USD 150,000, the fund focuses on listed small-cap companies in India that exhibit strong fundamentals, scalable business models, and high growth potential. You're reading Entrepreneur India, an international franchise of Entrepreneur Media. Equirus Asset Manager, part of the Equirus Group, has announced the launch of its latest investment vehicle, the 'Equirus Long Horizon Offshore Investments Fund.' Registered under the International Financial Services Centres Authority (IFSCA) as a Category III Alternative Investment Fund (AIF), the open-ended fund is based in GIFT City and is denominated in US dollars. It is tailored for global investors looking to tap into the long-term growth potential of Indian small-cap equities. With a minimum investment requirement of USD 150,000, the fund focuses on listed small-cap companies in India that exhibit strong fundamentals, scalable business models, and high growth potential. The fund is benchmark-agnostic and adopts a bottom-up, research-driven approach, emphasising disciplined investing and earnings-based stock selection. Sahil Shah, Chief Investment Officer at Equirus Asset Manager, highlighted, "India is entering a multi-decade growth cycle fueled by manufacturing momentum and a rising consumption-driven middle class. Small caps offer the most direct exposure to these trends. Our aim is to support high-quality businesses at pivotal stages in their growth journey." The fund is structured to provide a tax-efficient gateway for global investors, including Non-Resident Indians (NRIs) and Overseas Citizens of India (OCIs). It draws on Equirus's established onshore investment strategy, which has delivered a compounded annual growth rate of 21.6 percent over more than eight years. Ajaykumar Gupta, Chief Business Officer at Equirus Asset Manager, noted, "This fund is more than a financial instrument. It connects global investors to the next chapter of India's economic rise. As the country advances toward becoming a 10 trillion dollar economy, our fund offers a transparent and compliant structure for participating in that transformation." Equirus's small-cap strategy is grounded in identifying companies capable of compounding earnings significantly above India's nominal GDP growth. The fund maintains a diversified portfolio of 20 to 25 businesses, ensuring a balance between risk management and focused capital allocation. As global interest in Indian equities increases, particularly in the under-researched small-cap segment, the new fund positions itself as a timely opportunity for long-term investors.
Yahoo
3 days ago
- Business
- Yahoo
Exploring 3 Promising Undervalued Small Caps With Insider Activity In The European Market
As the European market navigates through a landscape marked by fluctuating trade dynamics and mixed economic signals, the pan-European STOXX Europe 600 Index has shown resilience with a recent uptick of 1.15%, despite looming tariff concerns from the U.S. In this environment, identifying promising small-cap stocks can be particularly rewarding, especially those that exhibit strong fundamentals and insider activity, which may suggest confidence in their potential amidst broader market uncertainties. Top 10 Undervalued Small Caps With Insider Buying In Europe Name PE PS Discount to Fair Value Value Rating Hoist Finance 8.7x 1.8x 20.10% ★★★★★☆ A.G. BARR 19.5x 1.8x 46.18% ★★★★☆☆ Yubico 32.4x 4.6x 12.21% ★★★★☆☆ Renold 10.6x 0.7x 3.17% ★★★★☆☆ CVS Group 44.4x 1.3x 39.97% ★★★★☆☆ Seeing Machines NA 2.7x 47.71% ★★★★☆☆ Nyab 23.4x 1.0x 32.11% ★★★☆☆☆ NOTE 21.1x 1.4x -8.58% ★★★☆☆☆ Lords Group Trading NA 0.2x -6.12% ★★★☆☆☆ Karnov Group 227.7x 4.8x 28.97% ★★★☆☆☆ Click here to see the full list of 53 stocks from our Undervalued European Small Caps With Insider Buying screener. Here we highlight a subset of our preferred stocks from the screener. Foxtons Group Simply Wall St Value Rating: ★★★★★☆ Overview: Foxtons Group is a UK-based real estate agency specializing in property sales, lettings, and financial services with a market cap of approximately £0.12 billion. Operations: Foxtons Group generates revenue primarily from Lettings (£106.03 million), Sales (£48.57 million), and Financial Services (£9.33 million). The company has experienced fluctuations in its net income margin, which was 24.76% in September 2014 but showed a decline to -15.42% by December 2018 before recovering to reach positive figures again, such as 8.54% by December 2024. Operating expenses have consistently been a significant portion of the company's costs, impacting overall profitability over time. PE: 13.7x Foxtons Group, a notable player in the European market, saw a revenue jump to £44.1 million for Q1 2025 from £35.7 million the previous year, highlighting its growth potential. Despite relying solely on external borrowing for funding, which poses higher risk, insider confidence is evident with recent share purchases by executives. The company also approved a final dividend of 0.95 pence per share in May 2025, indicating shareholder-friendly policies amidst projections of annual earnings growth at 12%. Take a closer look at Foxtons Group's potential here in our valuation report. Gain insights into Foxtons Group's historical performance by reviewing our past performance report. Zigup Simply Wall St Value Rating: ★★★★☆☆ Overview: Zigup operates in the rental and claims services sectors, with a focus on the UK, Ireland, and Spain markets, and has a market capitalization of £1.75 billion. Operations: Zigup generates revenue primarily from UK&I Rental, Spain Rental, and Claims & Services. The company's gross profit margin has shown fluctuations, peaking at 29.54% in late 2022 before declining to 21.95% by mid-2025. Operating expenses have steadily increased over time, impacting the overall profitability of the business. PE: 9.5x Zigup's recent earnings call on July 9, 2025, revealed a mixed financial landscape. Despite a decline in net income to £79.85 million from £125.02 million the previous year, sales rose to £682.89 million from £649.27 million, indicating potential for revenue growth. Insider confidence is evident with recent share purchases by executives over the past year, suggesting optimism about future prospects despite current challenges like lower profit margins and reliance on external borrowing for funding. Navigate through the intricacies of Zigup with our comprehensive valuation report here. Understand Zigup's track record by examining our Past report. BICO Group Simply Wall St Value Rating: ★★★☆☆☆ Overview: BICO Group is a biotechnology company specializing in bioprinting, lab automation, and life science solutions with a market cap of SEK 6.15 billion. Operations: The company's revenue is derived from three primary segments: Bioprinting (SEK 401.30 million), Lab Automation (SEK 447.20 million), and Life Science Solutions (SEK 1.02 billion). The gross profit margin has shown variability, with a notable decline to 49.25% in recent periods. PE: -8.1x BICO Group, a smaller European company, faces challenges with declining earnings and reliance on external borrowing. In the first quarter of 2025, sales dropped to SEK 388.6 million from SEK 470.2 million the previous year, while net losses widened significantly to SEK 234 million. Recent executive changes include appointing Lars Risberg as General Counsel and board reshuffles. These shifts may signal strategic realignment as BICO navigates its financial hurdles and explores future growth opportunities in its industry niche. Click here to discover the nuances of BICO Group with our detailed analytical valuation report. Assess BICO Group's past performance with our detailed historical performance reports. Taking Advantage Access the full spectrum of 53 Undervalued European Small Caps With Insider Buying by clicking on this link. Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks. Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world. Seeking Other Investments? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include LSE:FOXT LSE:ZIG and OM:BICO. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Melden Sie sich an, um Ihr Portfolio aufzurufen.
Yahoo
3 days ago
- Business
- Yahoo
Unearthing Three Promising Small Cap Stocks in Asia
As global markets navigate the complexities of new tariffs and mixed economic signals, Asian small-cap stocks are attracting attention for their potential resilience and growth prospects. In this context, identifying promising small-cap stocks involves looking for companies that can adapt to changing trade dynamics while maintaining strong fundamentals. Top 10 Undiscovered Gems With Strong Fundamentals In Asia Name Debt To Equity Revenue Growth Earnings Growth Health Rating Xuchang Yuandong Drive ShaftLtd 0.03% -13.23% -30.14% ★★★★★★ TCM Biotech International 2.98% 5.76% -0.13% ★★★★★★ Showbox NA 10.08% 7.87% ★★★★★★ Suzhou Sepax Technologies 0.04% 21.44% 34.83% ★★★★★★ Hokkan Holdings 66.84% -5.71% 18.42% ★★★★★☆ Nikko 29.66% 6.43% -3.15% ★★★★★☆ Hong Leong Finance 0.07% 6.89% 6.61% ★★★★★☆ KC 2.19% 8.76% -0.47% ★★★★★☆ Huang Hsiang Construction 268.99% 13.29% 10.70% ★★★★☆☆ Shanghai Material Trading 3.58% -6.74% -5.92% ★★★★☆☆ Click here to see the full list of 2608 stocks from our Asian Undiscovered Gems With Strong Fundamentals screener. We're going to check out a few of the best picks from our screener tool. Zhejiang Cheng Yi Pharmaceutical Simply Wall St Value Rating: ★★★★★☆ Overview: Zhejiang Cheng Yi Pharmaceutical Co., Ltd. operates in the pharmaceutical industry and has a market cap of CN¥4.15 billion. Operations: Cheng Yi Pharmaceutical generates revenue from its operations in the pharmaceutical industry, with a market capitalization of CN¥4.15 billion. Zhejiang Cheng Yi Pharmaceutical, with its robust earnings growth of 37.2% over the past year, outperformed the broader Pharmaceuticals industry, which saw a -2.5% change. Despite a volatile share price recently, it trades at 31.3% below estimated fair value, suggesting potential undervaluation. The company reported net income of CNY 200.7 million for 2024 and basic earnings per share rose to CNY 0.61 from CNY 0.50 last year, reflecting strong financial health despite an increased debt-to-equity ratio from 1.3% to 14.9%. A notable one-off gain of CN¥60 million also influenced recent results positively. Get an in-depth perspective on Zhejiang Cheng Yi Pharmaceutical's performance by reading our health report here. Gain insights into Zhejiang Cheng Yi Pharmaceutical's historical performance by reviewing our past performance report. Moon Environment TechnologyLtd Simply Wall St Value Rating: ★★★★★★ Overview: Moon Environment Technology Co., Ltd. engages in the refrigeration and air conditioning industry both within China and internationally, with a market capitalization of CN¥11.70 billion. Operations: Moon Environment Technology Co., Ltd. generates revenue through its operations in the refrigeration and air conditioning sectors, serving both domestic and international markets. The company has a market capitalization of CN¥11.70 billion. Moon Environment Technology, a small player in the machinery sector, offers an intriguing mix of financial metrics. Despite a 10.7% negative earnings growth last year, the company is projected to boost earnings by 12.71% annually. Trading at 41.3% below its estimated fair value suggests potential upside for investors seeking undervalued opportunities. The debt-to-equity ratio has improved significantly from 25.5% to 14% over five years, reflecting prudent financial management with more cash than total debt on hand and positive free cash flow reported consistently. Recent events include a stock split and dividend approval, indicating shareholder-friendly policies amidst executive changes and updated bylaws. Delve into the full analysis health report here for a deeper understanding of Moon Environment TechnologyLtd. Gain insights into Moon Environment TechnologyLtd's past trends and performance with our Past report. Hamaton Automotive Technology Simply Wall St Value Rating: ★★★★★★ Overview: Hamaton Automotive Technology Co., Ltd is a global manufacturer and supplier of automotive products, with a market capitalization of CN¥5.29 billion. Operations: Hamaton Automotive Technology generates revenue primarily from its car parts segment, which contributed CN¥1.07 billion. Hamaton Automotive Technology, a small cap player in the auto components sector, showcases a robust financial profile. Over the past five years, its earnings have grown an impressive 22.2% annually, while maintaining a healthy debt-to-equity ratio that has significantly decreased from 49.7% to just 1%. The company also enjoys high-quality earnings and positive free cash flow. Recent performance highlights include net income of CNY 123.62 million for 2024 and a first-quarter net income of CNY 36.93 million in 2025, reflecting solid operational efficiency despite slightly lower quarterly sales compared to last year. Click to explore a detailed breakdown of our findings in Hamaton Automotive Technology's health report. Learn about Hamaton Automotive Technology's historical performance. Summing It All Up Click here to access our complete index of 2608 Asian Undiscovered Gems With Strong Fundamentals. Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools. Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors. Want To Explore Some Alternatives? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SHSE:603811 SZSE:000811 and SZSE:300643. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 days ago
- Business
- Yahoo
Unearthing Three Promising Small Cap Stocks in Asia
As global markets navigate the complexities of new tariffs and mixed economic signals, Asian small-cap stocks are attracting attention for their potential resilience and growth prospects. In this context, identifying promising small-cap stocks involves looking for companies that can adapt to changing trade dynamics while maintaining strong fundamentals. Top 10 Undiscovered Gems With Strong Fundamentals In Asia Name Debt To Equity Revenue Growth Earnings Growth Health Rating Xuchang Yuandong Drive ShaftLtd 0.03% -13.23% -30.14% ★★★★★★ TCM Biotech International 2.98% 5.76% -0.13% ★★★★★★ Showbox NA 10.08% 7.87% ★★★★★★ Suzhou Sepax Technologies 0.04% 21.44% 34.83% ★★★★★★ Hokkan Holdings 66.84% -5.71% 18.42% ★★★★★☆ Nikko 29.66% 6.43% -3.15% ★★★★★☆ Hong Leong Finance 0.07% 6.89% 6.61% ★★★★★☆ KC 2.19% 8.76% -0.47% ★★★★★☆ Huang Hsiang Construction 268.99% 13.29% 10.70% ★★★★☆☆ Shanghai Material Trading 3.58% -6.74% -5.92% ★★★★☆☆ Click here to see the full list of 2608 stocks from our Asian Undiscovered Gems With Strong Fundamentals screener. We're going to check out a few of the best picks from our screener tool. Zhejiang Cheng Yi Pharmaceutical Simply Wall St Value Rating: ★★★★★☆ Overview: Zhejiang Cheng Yi Pharmaceutical Co., Ltd. operates in the pharmaceutical industry and has a market cap of CN¥4.15 billion. Operations: Cheng Yi Pharmaceutical generates revenue from its operations in the pharmaceutical industry, with a market capitalization of CN¥4.15 billion. Zhejiang Cheng Yi Pharmaceutical, with its robust earnings growth of 37.2% over the past year, outperformed the broader Pharmaceuticals industry, which saw a -2.5% change. Despite a volatile share price recently, it trades at 31.3% below estimated fair value, suggesting potential undervaluation. The company reported net income of CNY 200.7 million for 2024 and basic earnings per share rose to CNY 0.61 from CNY 0.50 last year, reflecting strong financial health despite an increased debt-to-equity ratio from 1.3% to 14.9%. A notable one-off gain of CN¥60 million also influenced recent results positively. Get an in-depth perspective on Zhejiang Cheng Yi Pharmaceutical's performance by reading our health report here. Gain insights into Zhejiang Cheng Yi Pharmaceutical's historical performance by reviewing our past performance report. Moon Environment TechnologyLtd Simply Wall St Value Rating: ★★★★★★ Overview: Moon Environment Technology Co., Ltd. engages in the refrigeration and air conditioning industry both within China and internationally, with a market capitalization of CN¥11.70 billion. Operations: Moon Environment Technology Co., Ltd. generates revenue through its operations in the refrigeration and air conditioning sectors, serving both domestic and international markets. The company has a market capitalization of CN¥11.70 billion. Moon Environment Technology, a small player in the machinery sector, offers an intriguing mix of financial metrics. Despite a 10.7% negative earnings growth last year, the company is projected to boost earnings by 12.71% annually. Trading at 41.3% below its estimated fair value suggests potential upside for investors seeking undervalued opportunities. The debt-to-equity ratio has improved significantly from 25.5% to 14% over five years, reflecting prudent financial management with more cash than total debt on hand and positive free cash flow reported consistently. Recent events include a stock split and dividend approval, indicating shareholder-friendly policies amidst executive changes and updated bylaws. Delve into the full analysis health report here for a deeper understanding of Moon Environment TechnologyLtd. Gain insights into Moon Environment TechnologyLtd's past trends and performance with our Past report. Hamaton Automotive Technology Simply Wall St Value Rating: ★★★★★★ Overview: Hamaton Automotive Technology Co., Ltd is a global manufacturer and supplier of automotive products, with a market capitalization of CN¥5.29 billion. Operations: Hamaton Automotive Technology generates revenue primarily from its car parts segment, which contributed CN¥1.07 billion. Hamaton Automotive Technology, a small cap player in the auto components sector, showcases a robust financial profile. Over the past five years, its earnings have grown an impressive 22.2% annually, while maintaining a healthy debt-to-equity ratio that has significantly decreased from 49.7% to just 1%. The company also enjoys high-quality earnings and positive free cash flow. Recent performance highlights include net income of CNY 123.62 million for 2024 and a first-quarter net income of CNY 36.93 million in 2025, reflecting solid operational efficiency despite slightly lower quarterly sales compared to last year. Click to explore a detailed breakdown of our findings in Hamaton Automotive Technology's health report. Learn about Hamaton Automotive Technology's historical performance. Summing It All Up Click here to access our complete index of 2608 Asian Undiscovered Gems With Strong Fundamentals. Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools. Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors. Want To Explore Some Alternatives? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SHSE:603811 SZSE:000811 and SZSE:300643. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
News.com.au
3 days ago
- Business
- News.com.au
Tony's Takeaway: Specials on the biotech buffet
Tony tucks into some fresh biotech stocks on that he will be keenly watching after a sector down period has left some bargains on the menu. Tony Locantro has been a client advisor/investment manager in the stockbroking industry since 1998. He's focused on the small cap and emerging companies with a strong interest in identifying those in the mining, biotech and industrial sectors that offer growth potential. He also delves into the psychology of speculation and provides regular insights on a number of social media and finance related outlets. This time, Tony tucks in his napkin and into some fresh ASX biotech stocks on that he will be keenly watching after a sector down period has left some potential bargains on the menu. The views, information, or opinions expressed in this video are solely those of the author and do not represent the views of Stockhead. Stockhead has not provided, endorsed or otherwise assumed responsibility for any financial product advice contained in this video. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.
